Mind the gap in kidney care: translating what we know into what we do

Author:

Luyckx Valerie A.1,Tuttle Katherine R.2,Abdellatif Dina3,Correa-Rotter Ricardo4,Fung Winston W.S.5,Haris Agnès6,Hsiao Li-Li7,Khalife Makram8,Kumaraswami Latha A.9,Loud Fiona8,Raghavan Vasundhara8,Roumeliotis Stefanos10,Sierra Marianella8,Ulasi Ifeoma11,Wang Bill8,Lui Siu-Fai12,Liakopoulos Vassilios10,Balducci Alessandro13,For the World Kidney Day Joint Steering Committee. .

Affiliation:

1. Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich; Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School; Department of Paediatrics and Child Health, University of Cape Town

2. Providence Medical Research Center, Providence Inland Northwest Health; Nephrology Division, Department of Medicine, University of Washington

3. Department of Nephrology, Cairo University Hospital

4. Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubiran

5. Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong

6. Nephrology Department, Péterfy Hospital

7. Renal Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School

8. ISN Patient Liaison Advisory Group

9. Tamilnad Kidney Research (TANKER) Foundation

10. 2nd Department of Nephrology, AHEPA University Hospital Medical School, Aristotle University of Thessaloniki

11. Department of Medicine, College of Medicine, University of Nigeria

12. Division of Health System, Policy and Management, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong

13. Italian Kidney Foundation

Abstract

Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we know and what we do. Clear guidelines exist for the prevention and management of common risk factors for kidney disease, such as hypertension and diabetes, but only a fraction of people with these conditions worldwide are diagnosed, and even fewer are treated to target. Similarly, the vast majority of people living with kidney disease are unaware of their condition, because in the early stages it is often silent. Even among patients who have been diagnosed, many do not receive appropriate treatment for kidney disease. Considering the serious consequences of kidney disease progression, kidney failure, or death, it is imperative that treatments are initiated early and appropriately. Opportunities to diagnose and treat kidney disease early must be maximized beginning at the primary care level. Many systematic barriers exist, ranging from patient to clinician to health systems to societal factors. To preserve and improve kidney health for everyone everywhere, each of these barriers must be acknowledged so that sustainable solutions are developed and implemented without further delay.

Publisher

Non-profit organization Nephrology

Reference67 articles.

1. Jager KJ, Kovesdy S, Langham R et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int 96 (2019):1048–1050

2. Institute for Health Metrics and Evaluation (IHME). GBD compare data visualization. Accessed November 18, 2023. http://vizhub.healthdata.org/gbd-compare

3. Luyckx VA, Tonelli M, Stanifer JW. The global burden of kidney disease and the sustainable development goals. Bull World Health Organ 96 (2018): 414–422D

4. International Society of Nephrology. ISN Global Kidney Health Atlas, 3rd ed. Accessed November 18, 2023. https://www.theisn.org/initiatives/global-kidney-health-atlas/

5. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395 (2020) 709–733

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3